GCA
DMTK

Greenwood Capital Associates’s DermTech, Inc. Common Stock DMTK Stock Holding History

Greenwood Capital Associates’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-32,687
Closed -$85K – 270
2023
Q2 		$85K Sell
32,687
-487
-1% -$1.46K 0.01% 234
2023
Q1 		$122K Buy
+33,174
New +$140K 0.02% 230

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WIC
Woodmont Investment Counsel Nashville, Tennessee $1.83B AUM 25.91% 1-Year Est. Return

Greenwood Capital Associates's DMTK Position: Q3 2023 in Review

Greenwood Capital Associates sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2023, closing a stake of 32,687 shares — an estimated $85K sold.

Greenwood Capital Associates first reported a position in DMTK in Q1 2023 and held it in 2 quarters. The position peaked at $122K in Q1 2023. 78 funds tracked by Wall St. Rank hold DMTK as of Q3 2023.

  • Greenwood Capital Associates reported no remaining DermTech, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Greenwood Capital Associates sold 32,687 DermTech, Inc. Common Stock shares in Q3 2023, an estimated $85K.
  • Greenwood Capital Associates first reported a position in DermTech, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
  • Greenwood Capital Associates's DermTech, Inc. Common Stock position peaked at $122K in Q1 2023.
  • 78 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2023.

Based on Greenwood Capital Associates's 13F filing for Q3 2023, filed 18 Oct 2023.